Patient with White-Coat Hypertension
Patient with Masked Hypertension
Patient with Isolated Diurnal Hypertension
Patient with Isolated Nocturnal Hypertension
Patient with Hypertension and OSA
Patient with Resistant Hypertension
Patient with Pseudo-Resistant Hypertension
Patient with Drug-Induced Hypotension
This book guides readers through the correct use and consequent diagnostic and therapeutic relevance of 24-h ambulatory blood pressure monitoring (ABPM) in a wide spectrum of clinical presentations and different phenotypes of arterial hypertension. On the basis of eight case studies, the author reviews and discusses current guidelines and recommendations aimed at optimizing the diagnostic and therapeutic approach in commonly encountered real-world clinical scenarios, including challenging cases of white-coat hypertension, masked hypertension, isolated nocturnal or diurnal hypertension, hypertension and obstructive sleep apnea, pseudo-resistant and true-resistant hypertension, and drug-induced hypotension. This handy and practical book provides physicians in the area of general and internal medicine, as well as specialists in cardiovascular risk, valuable insights for optimizing the treatment of these hypertensive patients.
• Describes decision-making in antihypertensive treatment combining clinical data and results of 24h ABPM
• Presents commonly encountered phenotypes of hypertensive patients, analizing real-world clinical scenarios
• Reviews and discusses current guidelines and recommendations
Julian Segura received his MD degree from the University of Alcalá (Madrid) and completed his residency and fellowship in nephrology at the Hospital “12 de Octubre” in Madrid, Spain. He started working at the Hypertension Unit at the same hospital in 1998, and has been head of the unit there since 2013.
His principal areas of interest are hypertension, the kidney, and cardiovascular risk factors. He has published several papers on the development and prevalence of renal damage in hypertensive patients, the relationship between hypertensive renal damage and cardiovascular risk, and the relevance of metabolic syndrome in hypertensive patients.
He is a member of the Spanish Ambulatory Blood Pressure Monitoring Registry’s Scientific Committee, the European Society of Hypertension (ESH), the Spanish Society of Nephrology and the International Society of Nephrology, and in March 2015 he was elected president of the Spanish Society of Hypertension. In 2001, he received the diploma of Clinical Hypertension Specialist supported by the ESH. From 2005 to 2014, he was the executive editor of the journal of the Spanish Society of Hypertension, and from 2008 to 2011, he was a member of the editorial board of the Journal of Hypertension. He acts as referee for several journals, including the Journal of Hypertension, Journal of Human Hypertension, and the Spanish Journal of Hypertension.